ArticleCase reports in oncological medicine2013
Nonalpine thyroid angiosarcoma in a patient with hashimoto thyroiditis.
Article in Case reports in oncological medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 12 citations in OpenAlex.
- Thyroid angiosarcoma: a rare malignancy - case report and systematic review of the literature.Thyroid research · 2025Review
- A Case Report of Surgical and Postoperative Treatment for Thyroid Angiosarcoma with Pulmonary Metastasis.Surgical case reports · 2025Article
- Non-alpine primary thyroid angiosarcoma.Archives of endocrinology and metabolism · 2022Article
- Primary Angiosarcoma of the Thyroid in an Asian Woman: A Case Report with Review of the Literature.Case reports in pathology · 2020Article
- Primary thyroid angiosarcoma in a non-endemic region - a rare case.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie · 2020Article
- Primary Epithelioid Angiosarcoma of the Thyroid in a Patient Occupationally Exposed to Radiations.Frontiers in endocrinology · 2018Article
- Epithelioid angiosarcoma of the thyroid gland without distant metastases at diagnosis: report of six cases with a long follow-up.Virchows Archiv : an international journal of pathology · 2016Article
- An extremely rare case of thyroid malignancy from the non-Alpine region: Angiosarcoma.International journal of surgery case reports · 2016Article
- Epithelioid angiosarcoma of the thyroid: report of a case from an italian non-alpine area and review of the literature.Endocrine pathology · 2015Review
- Invasive thyroid angiosarcoma with a favorable outcome.International journal of endocrinology and metabolism · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thyroid angiosarcoma is an uncommon thyroid carcinoma and its incidence is the highest in the European Alpine regions. Thyroid angiosarcoma is also a very aggressive tumor that can rapidly spread to the cervical lymph nodes, lungs, and brain or can metastasize to the duodenum, small boewl, and large bowel. Although it is histologically well defined, clear-cut separation between the angiosarcoma and anaplastic thyroid carcinoma is difficult. A 49-year-old Caucasian female patient, born and resident in Southern Italy (Calabria), in an iodine-sufficient area, was admitted to the Surgery Department because she presented with a painless mass in the anterior region of neck enlarged rapidly in the last three months. After total thyroidectomy and right cervical lymphadenectomy, postoperative histological examination revealed the presence of a thyroid angiosarcoma with positive staining for CD31 and for both Factor VIII-related antigen and Vimentin and only partially positive for staining pancytokeratin and presence of metastasis in cervical, supraclavicular, mediastinal and paratracheal lymph nodes. The patient started adjuvant chemotherapy and she was treated for 6 cycles with Doxorubicin, Dacarbazine, Ifosfamide, and Mesna (MAID). After 22 months from surgery, the patient is still alive without both local and systemic recurrence of the disease.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.